Combined Sodium-Glucose-Transporters Inhibitors and Glucagon-Like-Peptide Receptor Agonist Compared With Monotherapy Improves Long-Term Survival: A Real-World Registry

Autor: García-Vega, David, Cinza-Sanjurjo, Sergio, Eiras, Sonia, González-Juanatey, José Ramón
Zdroj: In The American Journal of Medicine August 2024 137(8):761-769
Databáze: ScienceDirect